---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-016706"
form_type: "8-K"
ticker: null
cik: "0001042074"
company_name: "CymaBay Therapeutics, Inc."
filed_at: "2024-01-26T23:59:59+00:00"
generated_at: "2026-06-06T16:21:42.776603+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CymaBay appoints Harish Shantharam as principal accounting officer; updates director comp

## Summary
- Daniel Menold ceased as principal accounting officer on Jan 24, 2024, remains an employee.
- Harish Shantharam (CFO) named principal accounting officer, in addition to his CFO role.
- Non-Employee Director Compensation amended: annual equity award valued at ~$250k; initial award ~$400k.
- Cash retainers unchanged: $40k annual base, $30k board chair, audit chair $20k, comp chair $15k, nominating chair $10k.

## SEC filing metadata
- accession: 0001193125-24-016706
- form_type: 8-K
- cik: 0001042074
- company_name: CymaBay Therapeutics, Inc.
- filed_at: 2024-01-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1042074/000119312524016706/0001193125-24-016706-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1042074/000119312524016706/d687696d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-016706
- JSON: https://secwatch.observer/filing/0001193125-24-016706.json
- Plain text: https://secwatch.observer/filing/0001193125-24-016706.txt

## Key facts
- Executive change
  Daniel Menold departed as principal accounting officer at CymaBay Therapeutics, Inc..
  - Action: ceased
  - Role: principal accounting officer
  source text: On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1042074/000119312524016706/0001193125-24-016706-index.htm
- Executive change
  Harish Shantharam was appointed as principal accounting officer at CymaBay Therapeutics, Inc..
  - Action: became
  - Role: principal accounting officer
  source text: On January 24, 2024, Daniel Menold ceased to be the principal accounting officer of CymaBay and Harish Shantharam became the principal accounting officer in addition to his role as principal financial officer and Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1042074/000119312524016706/0001193125-24-016706-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.